These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12628325)

  • 1. Design strategies to improve soluble macromolecular delivery constructs.
    Christie RJ; Grainger DW
    Adv Drug Deliv Rev; 2003 Feb; 55(3):421-37. PubMed ID: 12628325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved delivery of poorly soluble compounds using nanoparticle technology: a review.
    Kalepu S; Nekkanti V
    Drug Deliv Transl Res; 2016 Jun; 6(3):319-32. PubMed ID: 26891912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melt extrusion with poorly soluble drugs - An integrated review.
    Repka MA; Bandari S; Kallakunta VR; Vo AQ; McFall H; Pimparade MB; Bhagurkar AM
    Int J Pharm; 2018 Jan; 535(1-2):68-85. PubMed ID: 29102700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methods used in Pharmaceutical Technology to Increase Bioavailability of Poorly Soluble Drugs after Oral Administration].
    Vraníková B; Gajdziok J
    Ceska Slov Farm; 2015 Nov; 64(5):159-72. PubMed ID: 28649809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Patents in Pulmonary Delivery of Macromolecules.
    Ray A; Mandal A; Mitra AK
    Recent Pat Drug Deliv Formul; 2015; 9(3):225-36. PubMed ID: 26219931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supercritical fluid particle design for poorly water-soluble drugs (review).
    Sun Y
    Curr Pharm Des; 2014; 20(3):349-68. PubMed ID: 23651403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies.
    Du J; Li X; Zhao H; Zhou Y; Wang L; Tian S; Wang Y
    Int J Pharm; 2015 Nov; 495(2):738-49. PubMed ID: 26383838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol.
    Patel NR; Hatziantoniou S; Georgopoulos A; Demetzos C; Torchilin VP; Weissig V; D'Souza GG
    J Liposome Res; 2010 Sep; 20(3):244-9. PubMed ID: 19883213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-scale devices for transdermal drug delivery.
    Arora A; Prausnitz MR; Mitragotri S
    Int J Pharm; 2008 Dec; 364(2):227-36. PubMed ID: 18805472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.
    Chu TW; Kopeček J
    Biomater Sci; 2015 Jul; 3(7):908-22. PubMed ID: 26191406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in intravenous delivery of poorly water-soluble compounds.
    Shi Y; Porter W; Merdan T; Li LC
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-target residence time and its implications for lead optimization.
    Copeland RA; Pompliano DL; Meek TD
    Nat Rev Drug Discov; 2006 Sep; 5(9):730-9. PubMed ID: 16888652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and Delivery of Macromolecules.
    Morales JO
    AAPS PharmSciTech; 2017 Jan; 18(1):1-2. PubMed ID: 27943123
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-time multiple-particle tracking: applications to drug and gene delivery.
    Suh J; Dawson M; Hanes J
    Adv Drug Deliv Rev; 2005 Jan; 57(1):63-78. PubMed ID: 15518921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives.
    Alexander A; Ajazuddin ; Patel RJ; Saraf S; Saraf S
    J Control Release; 2016 Nov; 241():110-124. PubMed ID: 27663228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of drug materials and drug delivery systems.
    Bowker M
    Eur J Pharm Sci; 2002 Feb; 15(1):97-8. PubMed ID: 11803136
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioadhesive microspheres as a controlled drug delivery system.
    Vasir JK; Tambwekar K; Garg S
    Int J Pharm; 2003 Apr; 255(1-2):13-32. PubMed ID: 12672598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-drug conjugates: present state of play and future perspectives.
    Pang X; Du HL; Zhang HQ; Zhai YJ; Zhai GX
    Drug Discov Today; 2013 Dec; 18(23-24):1316-22. PubMed ID: 24055841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macromolecular drug delivery: basic principles and therapeutic applications.
    Belting M; Wittrup A
    Mol Biotechnol; 2009 Sep; 43(1):89-94. PubMed ID: 19475521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.